235 related articles for article (PubMed ID: 19910518)
21. Establishment of a Drug-Induced, Bile Acid-Dependent Hepatotoxicity Model Using HepaRG Cells.
Susukida T; Sekine S; Nozaki M; Tokizono M; Oizumi K; Horie T; Ito K
J Pharm Sci; 2016 Apr; 105(4):1550-60. PubMed ID: 26952880
[TBL] [Abstract][Full Text] [Related]
22. Assessment of drug interactions in hepatobiliary transport using rhodamine 123 in sandwich-cultured rat hepatocytes.
Annaert PP; Brouwer KL
Drug Metab Dispos; 2005 Mar; 33(3):388-94. PubMed ID: 15608134
[TBL] [Abstract][Full Text] [Related]
23. Fasiglifam (TAK-875) Inhibits Hepatobiliary Transporters: A Possible Factor Contributing to Fasiglifam-Induced Liver Injury.
Li X; Zhong K; Guo Z; Zhong D; Chen X
Drug Metab Dispos; 2015 Nov; 43(11):1751-9. PubMed ID: 26276582
[TBL] [Abstract][Full Text] [Related]
24. An experimental approach to evaluate the impact of impaired transport function on hepatobiliary drug disposition using Mrp2-deficient TR- rat sandwich-cultured hepatocytes in combination with Bcrp knockdown.
Yang K; Pfeifer ND; Hardwick RN; Yue W; Stewart PW; Brouwer KL
Mol Pharm; 2014 Mar; 11(3):766-75. PubMed ID: 24410402
[TBL] [Abstract][Full Text] [Related]
25. A Two-Tiered In Vitro Approach to De-Risk Drug Candidates for Potential Bile Salt Export Pump Inhibition Liabilities in Drug Discovery.
Hafey MJ; Houle R; Tanis KQ; Knemeyer I; Shang J; Chen Q; Baudy A; Monroe J; Sistare FD; Evers R
Drug Metab Dispos; 2020 Nov; 48(11):1147-1160. PubMed ID: 32943412
[TBL] [Abstract][Full Text] [Related]
26. Nimesulide and 4'-Hydroxynimesulide as Bile Acid Transporters Inhibitors Are Contributory Factors for Drug-Induced Cholestasis.
Zhou L; Pang X; Jiang J; Zhong D; Chen X
Drug Metab Dispos; 2017 May; 45(5):441-448. PubMed ID: 28202577
[TBL] [Abstract][Full Text] [Related]
27. Prediction of Altered Bile Acid Disposition Due to Inhibition of Multiple Transporters: An Integrated Approach Using Sandwich-Cultured Hepatocytes, Mechanistic Modeling, and Simulation.
Guo C; Yang K; Brouwer KR; St Claire RL; Brouwer KL
J Pharmacol Exp Ther; 2016 Aug; 358(2):324-33. PubMed ID: 27233294
[TBL] [Abstract][Full Text] [Related]
28. Secretin prevents taurocholate-induced intrahepatic cholestasis in the rat.
Fukumoto Y; Ando M; Yasunaga M; Okuda M; Okita K
J Hepatol; 1994 Jun; 20(6):750-4. PubMed ID: 7930475
[TBL] [Abstract][Full Text] [Related]
29. Hepatobiliary disposition in primary cultures of dog and monkey hepatocytes.
Rose KA; Kostrubsky V; Sahi J
Mol Pharm; 2006; 3(3):266-74. PubMed ID: 16749858
[TBL] [Abstract][Full Text] [Related]
30. Mechanistic Modeling of the Hepatic Disposition of Estradiol-17
Ito K; Sjöstedt N; Brouwer KLR
Drug Metab Dispos; 2020 Feb; 48(2):116-122. PubMed ID: 31744810
[TBL] [Abstract][Full Text] [Related]
31. Troglitazone-induced intrahepatic cholestasis by an interference with the hepatobiliary export of bile acids in male and female rats. Correlation with the gender difference in troglitazone sulfate formation and the inhibition of the canalicular bile salt export pump (Bsep) by troglitazone and troglitazone sulfate.
Funk C; Pantze M; Jehle L; Ponelle C; Scheuermann G; Lazendic M; Gasser R
Toxicology; 2001 Oct; 167(1):83-98. PubMed ID: 11557132
[TBL] [Abstract][Full Text] [Related]
32. Role of hepatic transporters in the disposition and hepatotoxicity of a HER2 tyrosine kinase inhibitor CP-724,714.
Feng B; Xu JJ; Bi YA; Mireles R; Davidson R; Duignan DB; Campbell S; Kostrubsky VE; Dunn MC; Smith AR; Wang HF
Toxicol Sci; 2009 Apr; 108(2):492-500. PubMed ID: 19223659
[TBL] [Abstract][Full Text] [Related]
33. Polygoni Multiflori Radix derived anthraquinones alter bile acid disposition in sandwich-cultured rat hepatocytes.
Kang L; Si L; Rao J; Li D; Wu Y; Wu S; Wu M; He S; Zhu W; Wu Y; Xu J; Li G; Huang J
Toxicol In Vitro; 2017 Apr; 40():313-323. PubMed ID: 28161596
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of bile acid transport across Na+/taurocholate cotransporting polypeptide (SLC10A1) and bile salt export pump (ABCB 11)-coexpressing LLC-PK1 cells by cholestasis-inducing drugs.
Mita S; Suzuki H; Akita H; Hayashi H; Onuki R; Hofmann AF; Sugiyama Y
Drug Metab Dispos; 2006 Sep; 34(9):1575-81. PubMed ID: 16760228
[TBL] [Abstract][Full Text] [Related]
35. [Evaluation of P-glycoprotein mediated in vitro loperamide biliary excretion with sandwich-cultured rat hepatocytes model].
Shen GL; Zhuang XM; Yuan M; Sun HX; Li H
Yao Xue Xue Bao; 2012 Apr; 47(4):459-65. PubMed ID: 22799027
[TBL] [Abstract][Full Text] [Related]
36. Role of Organic Solute Transporter Alpha/Beta in Hepatotoxic Bile Acid Transport and Drug Interactions.
Beaudoin JJ; Bezençon J; Sjöstedt N; Fallon JK; Brouwer KLR
Toxicol Sci; 2020 Jul; 176(1):34-35. PubMed ID: 32294204
[TBL] [Abstract][Full Text] [Related]
37. Quantification of Drug-Induced Inhibition of Canalicular Cholyl-l-Lysyl-Fluorescein Excretion From Hepatocytes by High Content Cell Imaging.
Barber JA; Stahl SH; Summers C; Barrett G; Park BK; Foster JR; Kenna JG
Toxicol Sci; 2015 Nov; 148(1):48-59. PubMed ID: 26220638
[TBL] [Abstract][Full Text] [Related]
38. Metabolic Activation of Cholestatic Drug-Induced Bile Acid-Dependent Toxicity in Human Sandwich-Cultured Hepatocytes.
Ogimura E; Tokizono M; Sekine S; Nakagawa T; Bando K; Ito K
J Pharm Sci; 2017 Sep; 106(9):2509-2514. PubMed ID: 28465153
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of bile salt transport by drugs associated with liver injury in primary hepatocytes from human, monkey, dog, rat, and mouse.
Zhang J; He K; Cai L; Chen YC; Yang Y; Shi Q; Woolf TF; Ge W; Guo L; Borlak J; Tong W
Chem Biol Interact; 2016 Aug; 255():45-54. PubMed ID: 27000539
[TBL] [Abstract][Full Text] [Related]
40. Automated applications of sandwich-cultured hepatocytes in the evaluation of hepatic drug transport.
Perry CH; Smith WR; St Claire RL; Brouwer KR
J Biomol Screen; 2011 Apr; 16(4):427-35. PubMed ID: 21393626
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
